Skip to content
AAHP 100 Years New Logo
  • About
    • About AAHP
    • Board & Committees
    • Homeopathy FAQs
  • Membership
    • About Membership
    • Become a Member
    • Member Directory
    • Member Log In
  • Events
  • Resources
    • News, Resources, & Updates
    • 100th Anniversary Report
      • 1: Mission of AAHP
      • 2: History of AAHP
      • 3: Regulatory Framework
      • 4: Future of Homeopathic Medicines
      • 5: Future of AAHP
      • 6: Research
      • 7: Homeopathy in the U.S.
      • 8: World History & Impact
    • Homeopathy Historical Survey
  • Consumer Center
  • Contact

Posts Tagged ‘fda’

Alert: FDA Drug Listing Records Subject to Inactivation

September 10, 2019

By Eric Foxman, AAHP Secretary   Beginning September 14, 2019, and every January, FDA will begin to inactivate drug listings that are uncertified in the previous renewal period. Last month,…

Read More

Archives

More Like This

  • The Hahnemann Monument: Its History and Its Architecture May 4, 2026
  • Christian Friedrich Samuel Hahnemann: A Very Brief Biography May 4, 2026
  • Preserving the Story of Homeopathy May 4, 2026
  • New FDA Draft Guidance on Responding to 483 Observations; What Drug Manufacturers Need to Know Now March 20, 2026
  • Stability Testing March 17, 2026

You Might Also Enjoy

  • Consumer FAQs
  • Aconite: A Clinical Snapshot
  • The Importance of Standard Operating Procedures
  • Don’t Skip the Mint
  • How to Use Gelsemium sempervirens
  • Calendula officinalis: A Clinical Snapshot
AAHP

Contact

Address:
1350 Main Street, Suite 400
Springfield, MA 01103

Answering service:
(413) 515-8133
info@theaahp.org

Privacy Policy
Code of Ethics

Quick Links

  • About
  • Join AAHP
  • Membership
  • Member Directory
  • Resources
  • Consumer Center
  • FAQs
  • Contact

© 2026 The American Association for Homeopathic Products. All Rights Reserved.

Scroll To Top